Alexandre Akoulitchev

Company: Oxford BioDynamics plc

Job title: Chief Scientific Officer

Seminars:

Companion Diagnostics for Immune Oncology with Episwitch® & 3D Genomics 4:00 pm

• PD-(L)1 Checkpoint Inhibitors – Relevant Predictive & Prognostic Assays • Targeted qPCR versus multi-variate assays on Agilent arrays • EpiSwitch Data Knowledge: Prognosis for prevention of immune-related adverse events (irAE's)Read more

day: Day Three PM